The 2-Minute Rule for Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors within the central nervous program, conolidine modulates alternate molecular targets. A Science Advancements review discovered that conolidine interacts With all the atypical chemokine receptor ACKR3/CX